Company / Net Debt per Share
PROCEPT BioRobotics Corp Net Debt per Share History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Net Debt per Share
-$4.23
FY2025
5-year range
-$15.43 / -$3.84
FY2021-FY2025
Trend
+21.9%
vs FY2024
Sector context
#92 of 97
Health Care
What the data says
Among 97 Health Care companies, PROCEPT BioRobotics Corp is in the top 5% for net debt per share. Net Debt per Share returned to growth in FY2025 after 2 years of decline, reaching $-4.23.
Based on SEC 10-K filings.
-4.23 in FY2025.
Increased from $-4.36 to $-4.23 over the past 2 years.
Health Care sector context is included.
Net Debt per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Top 5% in Health CareTop 5% of 97This company -$4.23 Sector average $16.14
▼
-126.2% below sector average
Key checks
Key Insights
- In FY2025, net debt per share increased 21.9% year-over-year.
- Ranks #92 out of 97 companies in the Health Care sector.
- Peak net debt per share was recorded in FY2022.
- Lowest net debt per share in the period was in FY2021.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Net Debt per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$4.23 | +21.9% |
| FY2024 | -$5.41 | -24.3% |
| FY2023 | -$4.36 | -13.4% |
| FY2022 | -$3.84 | +75.1% |
| FY2021 | -$15.43 | -1.4% |
| FY2020 | -$15.21 | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026